Democrats escalate probe of Trump admin drug pricing deals
Congressional Democrats are demanding pharmaceutical companies immediately disclose the un-redacted details of their “most favored nation” agreements with the Trump administration, according to a source familiar with the effort. The request to drugmakers comes from the potential health policy leaders in Congress next year — Democratic Reps. Frank Pallone Jr. (N.J.) of the Energy and...
Read the full story on The Hill → Opens the original article on thehill.comSummary aggregated from The Hill's public RSS feed. The full reporting belongs to The Hill — please read it on their site.